2025-08-29 09:02:45
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Metropolis Healthcare Ltd posts Rs. 58.26 crore consolidated net profit in Q2FY22
Posted On : 2021-11-10 22:12:21( TIMEZONE : IST )
Metropolis Healthcare Limited has reported Consolidated financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 308.1924 crores during the period ended September 30, 2021 as compared to Rs. 330.5276 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 58.2665 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 74.89 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 11.34 for the period ended September 30, 2021 as compared to Rs. 14.58 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 308.1924 crs | ₹330.5276 crs |  -6.76% |
| Net Profit | ₹58.2665 crs | ₹74.89 crs | -22.20% |
| EPS | ₹11.34 | ₹14.58 | -22.22% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 308.1924 crores during the period ended September 30, 2021 as compared to Rs.291.4352 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.58.2665 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.60.2788 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.11.34 for the period ended September 30, 2021 as compared to Rs.11.80 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 308.1924 crs | ₹291.4352 crs |  5.75% |
| Net Profit | ₹58.2665 crs | ₹60.2788 crs | -3.34% |
| EPS | ₹11.34 | ₹11.80 | -3.90% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.638.7200 crores during the 6 Months period ended September 30, 2021 as compared to Rs.437.7176 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.133.1565 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.63.1793 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.25.92 for the 6 Months period ended September 30, 2021 as compared to Rs.12.37 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹638.7200 crs | ₹437.7176 crs | 45.92% |
| Net Profit | ₹133.1565 crs | ₹63.1793 crs | 110.76% |
| EPS | ₹25.92 | ₹12.37 | 109.54% |
Shares of Metropolis Healthcare Limited was last trading in BSE at Rs. 3168.20 as compared to the previous close of Rs. 3180.70. The total number of shares traded during the day was 8523 in over 1394 trades.
The stock hit an intraday high of Rs. 3203.65 and intraday low of 3127.10. The net turnover during the day was Rs. 26954479.00.
